Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S SCHWARTZBERG

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomitingLee S Schwartzberg, Steven M Grunberg, Mark G Kris
Surgical Endoscopy|December 31, 1997
First trimester of pregnancy laparoscopic proceduresB S Schwartzberg, J A Conyers, J A Moore
The Journal of Supportive Oncology|November 4, 2006
A prospective investigation of chemotherapy-induced neutropenia and quality of lifeBarry V Fortner, Arthur C Houts, Lee S Schwartzberg
Future Oncology (London, England)|November 19, 2020
Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancerKaren E Skinner, Amin Haiderali, Min Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast CancerNamratha Vontela, Vamsi Koduri, Lee S Schwartzberg, et al.
Journal of Comparative Effectiveness Research|November 10, 2020
Assessing direct costs of treating metastatic triple-negative breast cancer in the USAKaren E Skinner, Amin Haiderali, Min Huang, et al.
Critical Reviews in Oncology/Hematology|February 11, 2012
The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignanciesLee S Schwartzberg, Peter Jacobs, Panagiota Matsouka, et al.
Cancer Treatment and Research|January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancerC H Weaver, R Birch, L S Schwartzberg, et al.
The Breast Journal|September 19, 2019
Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancerKaren E Skinner, Temitope Olufade, Mark S Walker, et al.
Clinical Breast Cancer|February 26, 2014
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancerLee S Schwartzberg, Suprith Badarinath, Mark R Keaton, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomitingLee S Schwartzberg, Steven M Grunberg, Mark G Kris
Surgical Endoscopy|December 31, 1997
First trimester of pregnancy laparoscopic proceduresB S Schwartzberg, J A Conyers, J A Moore
The Journal of Supportive Oncology|November 4, 2006
A prospective investigation of chemotherapy-induced neutropenia and quality of lifeBarry V Fortner, Arthur C Houts, Lee S Schwartzberg
Future Oncology (London, England)|November 19, 2020
Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancerKaren E Skinner, Amin Haiderali, Min Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast CancerNamratha Vontela, Vamsi Koduri, Lee S Schwartzberg, et al.
Journal of Comparative Effectiveness Research|November 10, 2020
Assessing direct costs of treating metastatic triple-negative breast cancer in the USAKaren E Skinner, Amin Haiderali, Min Huang, et al.
Critical Reviews in Oncology/Hematology|February 11, 2012
The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignanciesLee S Schwartzberg, Peter Jacobs, Panagiota Matsouka, et al.
Cancer Treatment and Research|January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancerC H Weaver, R Birch, L S Schwartzberg, et al.
The Breast Journal|September 19, 2019
Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancerKaren E Skinner, Temitope Olufade, Mark S Walker, et al.
Clinical Breast Cancer|February 26, 2014
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancerLee S Schwartzberg, Suprith Badarinath, Mark R Keaton, et al.
Pageof 23